Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses
Open Access
- 1 June 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 198 (11) , 4205-4209
Abstract
TLR agonists are currently being developed and tested as adjuvants in various formulations to optimize the immunogenicity and efficacy of vaccines. The aim of this study was to evaluate the immunostimulatory properties of a novel compound incorporating covalently linked moieties designed to stimulate both TLR2 and TLR7. This dual TLR2/TLR7 agonist induced the maturation of dendritic cells and primed substantial populations of cytolytic and highly polyfunctional effector CD8+ T cells in vitro, and safely potentiated the immunogenic properties of a nanoparticulate Ag in vivo, eliciting humoral responses with a balanced TH1/TH2 profile in mice. Collectively, these data reveal the potential utility of chimeric adjuvants with synergistic activities mediated via TLRs.Keywords
This publication has 27 references indexed in Scilit:
- Triggering Intracellular Receptors for Vaccine AdjuvantationTrends in Immunology, 2016
- Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-κB signaling pathwayScientific Reports, 2016
- Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands as Influenza Virus Vaccine Adjuvants Induce Rapid, Sustained, and Broadly Protective ResponsesJournal of Virology, 2015
- Cutting Edge: New Chimeric NOD2/TLR2 Adjuvant Drastically Increases Vaccine ImmunogenicityThe Journal of Immunology, 2014
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Generation of Th1-Polarizing Dendritic Cells Using the TLR7/8 Agonist CL075The Journal of Immunology, 2010
- Cutting Edge: TLR2 Directly Triggers Th1 Effector FunctionsThe Journal of Immunology, 2007
- Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal modelsJournal of Controlled Release, 2006
- HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+T cell responses in nonhuman primatesProceedings of the National Academy of Sciences, 2005
- Cutting Edge: Activation of Toll-Like Receptor 2 Induces a Th2 Immune Response and Promotes Experimental AsthmaThe Journal of Immunology, 2004